Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 |
|---|---|---|---|---|---|---|
| 1 | BMN 110 | - | - | - | - | 1件: 19 19 💬
|
| 2 | BMN 110 - every other week | - | - | - | - | 1件: 19 19 💬
|
| 3 | BMN 110 - weekly | - | - | - | - | 1件: 19 19 💬
|
| 4 | BMN 110 every other week | - | - | - | - | 1件: 19 19 💬
|
| 5 | BMN 110 weekly | - | - | - | - | 1件: 19 19 💬
|
| 6 | Recombinant human N-acetylgalactosamine 6-sulfatase, BMN 110 | - | - | - | - | 1件: 19 19 💬
|
| 7 | Recombinant human N-acetylgalactosamine-6-sulfatase, BMN 110 | 1件: Elosulfase alfa Elosulfase alfa | 1件: Elosulfase alfa
Elosulfase alfa
💬
| 1件: GALNS GALNS 💬
| 2件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome 💬 | 1件: 19 19 💬
|
| 8 | Recombinant human N-acetylgalactosamine-6-sulfatase, BMN 110 drug substance | 1件: Elosulfase alfa Elosulfase alfa | 1件: Elosulfase alfa
Elosulfase alfa
💬
| 1件: GALNS GALNS 💬
| 2件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome 💬 | 1件: 19 19 💬
|